Thomas K Langbein's Net Worth

$18.5 Million

Estimate Recalculated Sep 8, 2024 07:23PM EST

Who is Thomas K Langbein?

Thomas K Langbein has an estimated net worth of $18.5 Million. This is based on reported shares across multiple companies, which include DIALYSIS CORP OF AMERICA, and MEDICORE INC.

SEC CIK

Thomas K Langbein's CIK is 0000923827

Past Insider Trading and Trends

2004 was Thomas K Langbein's most active year for acquiring shares with 4 total transactions. Thomas K Langbein's most active month to acquire stocks was the month of January. 2005 was Thomas K Langbein's most active year for disposing of shares, totalling 23 transactions. Thomas K Langbein's most active month to dispose stocks was the month of October. 2004 saw Thomas K Langbein paying a total of $416,571.25 for 595,714 shares, this is the most they've acquired in one year. In 2010 Thomas K Langbein cashed out on 1,461,711 shares for a total of $16,303,623.75, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

DIALYSIS CORP OF AMERICA No price found

Chm., Chf. Strategic Alliance

Thomas K Langbein owns 445,714 units of common stock, $.01 par value, 1,610,957 units of common stock, $.01 par value per share. Thomas K Langbein used to own units in common stock but no longer holds any shares there.acquired a total of 1,666,957 shares in DIALYSIS CORP OF AMERICA at a cost of $479,571.25, Thomas also disposed a total of 1,736,543 shares of DIALYSIS CORP OF AMERICA equalling to $18,974,516.13.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-1.45M
$11.25
-$16,303,623.75
0
Jun 2
Form 4
-0.86%
-12.50K
—
—
1.45M
Jan 8 - Feb 5
Form 4
+0.27%
4K
—
—
1.46M
Jun 11
Form 4
-0.05%
-700.00
—
—
1.46M
May 6
Form 4
+0.14%
2K
—
—
1.46M
Feb 27
Form 4
-0.36%
-5.30K
—
—
1.46M
Jan 16
Form 4
-0.27%
-4.00K
—
—
1.46M
May 1
Form 4
-0.13%
-1.90K
$13.87
-$26,353.00
1.47M
Jan 12
Form 4
-0.14%
-2.10K
$13.85
-$1,385.00
1.47M
Jan 2 - Jan 9
Form 4
+2.37%
34.45K
$8.48
-$9.78
1.49M
Mar 7
Form 4
-4.60%
-70.00K
$13.51
-$945,845.80
1.45M
Nov 22 - Nov 23
Form 4
-2.58%
-40.00K
$12.69
-$507,600.00
1.51M
Nov 17 - Nov 18
Form 4
-3.72%
-60.00K
$12.77
-$766,384.50
1.55M
Nov 11 - Nov 15
Form 4
+261.43%
1.17M
—
—
1.61M
Sep 21
Form 4
-4.31%
-20.06K
—
—
445.71K
Jan 3
Form 4
—
0
—
—
0
Jun 7
Form 4
+183.50%
301.48K
$2.37
-$0.55
465.78K
Mar 25
Form 4
+121.17%
90.01K
$0.63
$56,257.50
164.3K
Feb 6
No matching records found

MEDICORE INC No price found

CEO and President

Thomas K Langbein used to own units in common stock but no longer holds any shares there.acquired a total of 689,218 shares in MEDICORE INC at a cost of $399,120.84, Thomas also disposed a total of 1,901,014 shares of MEDICORE INC equalling to $432,120.97.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-1.31M
—
—
0
Sep 21
Form 4
+5.92%
73.44K
$7.09
-$14,888.76
1.31M
Jul 8
Form 4
-2.12%
-26.64K
$9.83
-$261,861.37
1.23M
Mar 29
Form 4
-9.38%
-130.00K
—
—
1.26M
Nov 16
Form 4
+7.78%
100K
$1.38
$138,000.00
1.39M
Feb 10
Form 4
-1.15%
-15.00K
$2.15
-$32,250.00
1.29M
Jan 2
Form 4
+8.33%
100K
$1.38
$138,000.00
1.3M
Sep 25
Form 4
—
0
—
—
0
No matching records found